Hypha Labs (FUNI) Cash from Investing Activities (2011 - 2025)
Hypha Labs' (FUNI) quarterly Cash from Investing Activities came in at -$31236.0 in Q3 2025, down 165.1% YoY from $47984.0 in Q3 2024, and down 3123700.0% on a QoQ basis from $1.0 in Q1 2025.
Hypha Labs (FUNI) Cash from Investing Activities (2011 - 2025) Analysis & Trends
Hypha Labs (FUNI) has 14 years of Cash from Investing Activities data on file, last reported at -$31236.0 in Q3 2025.
- Quarterly Cash from Investing Activities fell 165.1% year-over-year to -$31236.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$32966.0 (down 101.54% YoY) and the FY2025 annual result came in at -$32966.0, down 101.54% from the prior year.
- Cash from Investing Activities slipped to -$31236.0 in Q3 2025, from $1.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $2.1 million in Q1 2024 to a low of -$408482.0 in Q4 2021.
- A 5-year average of $96163.1 and a median of -$1731.0 in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities jumped 1487.51% — and 2025, when it plunged 165.1%.
- Tracing FUNI's Cash from Investing Activities over 5 years: stood at -$408482.0 in 2021, then jumped by 123.83% to $97334.0 in 2022, then sank by 111.99% to -$11667.0 in 2023, then surged by 85.16% to -$1731.0 in 2024, then slumped by 1704.51% to -$31236.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$31236.0 (Q3 2025), $1.0 (Q1 2025), and -$1731.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -25.50 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -32.14 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -134.00 Mn |
| 10 | Hypha Labs | 2.26 Mn | 2.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -31,236.00 |
| Sep 30, 2025 | -31,236.00 |
| Mar 31, 2025 | 1.00 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | -1,731.00 |
| Dec 31, 2024 | -1,731.00 |
| Sep 30, 2024 | 47,984.00 |
| Sep 30, 2024 | 47,984.00 |
| Jun 30, 2024 | -17,467.00 |
| Jun 30, 2024 | -17,467.00 |
| Mar 31, 2024 | 2.13 Mn |
| Mar 31, 2024 | 2.13 Mn |
| Dec 31, 2023 | -11,667.00 |
| Dec 31, 2023 | -11,667.00 |
| Jun 30, 2023 | 43,687.00 |
| Jun 30, 2023 | 43,687.00 |
| Mar 31, 2023 | 133,979.00 |
| Mar 31, 2023 | 133,979.00 |
| Dec 31, 2022 | 97,334.00 |
| Dec 31, 2022 | 97,334.00 |